TAILIEUCHUNG - KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease

This paper focuses on developing an empirical strategy for measuring the effect of pollution on health. Specifically, I look at the effect of air pollution on children's hospitalization for asthma. Childhood asthma is of particular interest for two reasons: 1) asthma is the leading chronic condition affecting children; and 2) current pollution standards are based on adult health responses to pollution and children face a greater risk from pollution exposure due to the sensitivity of their developing biological systems. This study builds on earlier work in five ways. First, I develop a unique, quarterly, zip. | OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF NEPHROLOGY kidney supplements KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease VOLUME 2 ISSUE 4 AUGUST 2 2012 http KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible Abbott Amgen Bayer Schering Pharma Belo Foundation Bristol-Myers Squibb Chugai Pharmaceutical Coca-Cola Company Dole Food Company Fresenius Medical Care Genzyme Hoffmann-LaRoche JC Penney Kyowa Hakko Kirin NATCO The Organization for Transplant Professionals NKF-Board of Directors Novartis Pharmacosmos PUMC Pharmaceutical Robert and Jane Cizik Foundation Shire Takeda Pharmaceutical Transwestern Commercial Services Vifor Pharma and Wyeth. Sponsorship Statement KDIGO is supported by a consortium of sponsors and no funding is accepted for the development of specific guidelines. contents http 2012 KDIGO VOL 2 ISSUE 41 AUGUST 2 2012 kidney INTERNATIONAL supplements KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease .0 v Tables and Figures vi KDIGO Board Members vii Reference Keys viii Abbreviations and Acronyms 279 Notice 280 Foreword 281 Work Group Membership 282 Abstract 283 Summary of Recommendation Statements 288 Chapter 1 Diagnosis and evaluation of anemia in CKD 292 Chapter 2 Use of iron to treat anemia in CKD 299 Chapter 3 Use of ESAs and other agents to treat anemia in CKD 311 Chapter 4 Red cell transfusion to treat anemia in CKD 317 Methods for Guideline Development 324 Biographic and Disclosure Information 330 Acknowledgments 331 .

• Sức khỏe trẻ em
• provides supporting
• limited ability
• Separability (RLS)
• Feature (Gene)
• Subset Selection
• Disease Gene Prioritization